Filing Details
- Accession Number:
- 0001447362-24-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-07 16:19:09
- Reporting Period:
- 2024-02-05
- Accepted Time:
- 2024-02-07 16:19:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236397 | Daniel Bradbury | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Suite 401 Friendswood TX 77546 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-05 | 2,751 | $22.74 | 61,944 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2024-02-05 | 2,963 | $22.74 | 38,870 | No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| Common Stock | Disposition | 2024-02-05 | 2,964 | $22.74 | 38,885 | No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
| Common Stock | Disposition | 2024-02-05 | 863 | $23.42 | 61,081 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2024-02-05 | 930 | $23.42 | 37,940 | No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| Common Stock | Disposition | 2024-02-05 | 931 | $23.42 | 37,954 | No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
| Common Stock | Disposition | 2024-02-06 | 3,121 | $23.63 | 57,960 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2024-02-06 | 3,362 | $23.63 | 34,578 | No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| Common Stock | Disposition | 2024-02-06 | 3,364 | $23.63 | 34,590 | No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,655 | Direct |
Footnotes
- The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023.
- This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
- Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
- Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
- This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
